These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429 [TBL] [Abstract][Full Text] [Related]
9. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116 [TBL] [Abstract][Full Text] [Related]
10. Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]β-CIT SPECT. Nocker M; Seppi K; Donnemiller E; Virgolini I; Wenning GK; Poewe W; Scherfler C Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1012-20. PubMed ID: 22460689 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Extrastriatal Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628 [No Abstract] [Full Text] [Related]
12. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914 [TBL] [Abstract][Full Text] [Related]
13. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism. Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132 [TBL] [Abstract][Full Text] [Related]
14. Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography. Messa C; Volonté MA; Fazio F; Zito F; Carpinelli A; d'Amico A; Rizzo G; Moresco RM; Paulesu E; Franceschi M; Lucignani G Eur J Nucl Med; 1998 Sep; 25(9):1270-6. PubMed ID: 9724376 [TBL] [Abstract][Full Text] [Related]
16. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study. Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926 [TBL] [Abstract][Full Text] [Related]
17. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images. Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542 [TBL] [Abstract][Full Text] [Related]
18. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome. Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391 [TBL] [Abstract][Full Text] [Related]
19. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism. Lee H; Sung YH; Hwang KH Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891 [TBL] [Abstract][Full Text] [Related]
20. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data. Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]